Key result
Abnormal QRS peaks predict ~50% greater odds of CRT response and decrease in responders over time.
Why the study?
Although QRS duration is an important determinant of CRT response, non-responder rates remain high, prompting investigation into whether quantification of abnormal QRS peaks could predict response.
Does quantification of abnormal QRS peaks (QRSp) predict response to cardiac resynchronization therapy in CRT patients?
Cohort (n=47)
Single-blind
Yes
Does quantification of abnormal QRS peaks (QRSp) predict response to cardiac resynchronization therapy in CRT patients?
Automated quantification of abnormal QRS peaks (QRSp) independently predicts CRT response and offers better specificity than QRS duration, particularly in patients with QRSd <150ms.
Answers are grounded in this paper and cite their sources.
Should not yet guide CRT selection; leaves open prospective validation of QRS peaks.
BACKGROUND: Although QRS duration (QRSd) is an important determinant of cardiac resynchronization therapy (CRT) response, non-responder rates remain high. QRS fragmentation can also reflect electrical dyssynchrony. We hypothesized that quantification of abnormal QRS peaks (QRSp) would predict CRT response. METHODS: Forty-seven CRT patients (left ventricular ejection fraction = 23±7%) were prospectively studied. Digital 12-lead ECGs were recorded during native rhythm at baseline and 6 months post-CRT. For each precordial lead, QRSp was defined as the total number of peaks detected on the unfiltered QRS minus those detected on a smoothed moving average template QRS. CRT response was defined as >5% increase in left ventricular ejection fraction post-CRT. RESULTS: Sixty-percent of patients responded to CRT. Baseline QRSd was similar in CRT responders and non-responders, and did not change post-CRT regardless of response. Baseline QRSp was greater in responders than non-responders (9.1±3.5 vs. 5.9±2.2, p = 0.001) and decreased in responders (9.2±3.6 vs. 7.9±2.8, p = 0.03) but increased in non-responders (5.5±2.3 vs. 7.5±2.8, p = 0.049) post-CRT. In multivariable analysis, QRSp was the only independent predictor of CRT response (Odds Ratio [95% Confidence Interval]: 1.5 [1.1-2.1], p = 0.01). ROC analysis revealed QRSp (area under curve = 0.80) to better discriminate response than QRSd (area under curve = 0.67). Compared to QRSd ≥150ms, QRSp ≥7 identified response with similar sensitivity but greater specificity (74 vs. 32%, p<0.05). Amongst patients with QRSd <150ms, more patients with QRSp ≥7 responded than those with QRSp <7 (75 vs. 0%, p<0.05). CONCLUSIONS: Our novel automated QRSp metric independently predicts CRT response and decreases in responders. Electrical dyssynchrony assessed by QRSp may improve CRT selection and track structural remodeling, especially in those with QRSd <150ms.
No takes yet. Share an insight, caveat, or question.
Suszko et al. (2019) conducted a cohort in Heart failure with ischemic or non-ischemic dilated cardiomyopathy (n=47). Abnormal QRS peaks (QRSp) vs. QRS duration (QRSd) was evaluated on CRT response (>5% increase in left ventricular ejection fraction post-CRT) (OR 1.5, 95% CI 1.1-2.1, p=0.01). Quantification of abnormal QRS peaks independently predicted functional response to cardiac resynchronization therapy (OR 1.5) and decreased in responders over time.
Synapse has enriched 10 related papers. Consider them for comparative context: